Pancreatic malignancy in the backdrop of chronic pancreatitis: How much to push the boundaries to achieve R0 resection

[1] Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. SiegelR MaJ ZouZ JemalA Cancer statistics, 2014 CA Cancer J Clin 2014 64 9 29 10.3322/caac.2120824399786 Search in Google Scholar

[2] Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246:173–80. BilimoriaKY BentremDJ KoCY StewartAK WinchesterDP TalamontiMS National failure to operate on early stage pancreatic cancer Ann Surg 2007 246 173 80 10.1097/SLA.0b013e3180691579193355017667493 Search in Google Scholar

[3] Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234:758–68. NeoptolemosJP StockenDD DunnJA AlmondJ BegerHG PederzoliP Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial Ann Surg 2001 234 758 68 10.1097/00000658-200112000-00007142213511729382 Search in Google Scholar

[4] Menon KV, Gomez D, Smith AM, Anthoney A, Verbeke CS. Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB (Oxford). 2009;11:18–24. MenonKV GomezD SmithAM AnthoneyA VerbekeCS Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP) HPB (Oxford) 2009 11 18 24 10.1111/j.1477-2574.2008.00013.x269787019590619 Search in Google Scholar

[5] Hartwig W, Hackert T, Hinz U, Gluth A, Bergmann F, Strobel O, et al. Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg. 2011;254:311–9. HartwigW HackertT HinzU GluthA BergmannF StrobelO Pancreatic cancer surgery in the new millennium: better prediction of outcome Ann Surg 2011 254 311 9 10.1097/SLA.0b013e31821fd33421606835 Search in Google Scholar

[6] Gnerlich JL, Luka SR, Deshpande AD, Dubray BJ, Weir JS, Carpenter DH, et al. Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma. Arch Surg. 2012;147:753–60. GnerlichJL LukaSR DeshpandeAD DubrayBJ WeirJS CarpenterDH Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma Arch Surg 2012 147 753 60 10.1001/archsurg.2012.112622911074 Search in Google Scholar

[7] Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007;246:52–60. RautCP TsengJF SunCC WangH WolffRA CraneCH Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Ann Surg 2007 246 52 60 10.1097/01.sla.0000259391.84304.2b189921617592291 Search in Google Scholar

[8] Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkenbijl JH, Bakkevold KE, et al. Influence of resection margins and treatment on survival in patients with pancreatic cancer: metaanalysis of randomized controlled trials. Arch Surg. 2008;143: 75–83. ButturiniG StockenDD WenteMN JeekelH KlinkenbijlJH BakkevoldKE Influence of resection margins and treatment on survival in patients with pancreatic cancer: metaanalysis of randomized controlled trials Arch Surg 2008 143 75 83 10.1001/archsurg.2007.1718209156 Search in Google Scholar

[9] Verbeke CS, Menon KV. Redefining resection margin status in pancreatic cancer. HPB (Oxford). 2009;11:282–9. VerbekeCS MenonKV Redefining resection margin status in pancreatic cancer HPB (Oxford) 2009 11 282 9 10.1111/j.1477-2574.2009.00055.x272708019718354 Search in Google Scholar

[10] Schlitter AM, Esposito I. Definition of microscopic tumor clearance (r0) in pancreatic cancer resections. Cancers (Basel). 2010;2:2001–2010. SchlitterAM EspositoI Definition of microscopic tumor clearance (r0) in pancreatic cancer resections Cancers (Basel) 2010 2 2001 2010 10.3390/cancers2042001384045724281214 Search in Google Scholar

[11] Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91:586–594. WagnerM RedaelliC LietzM SeilerCA FriessH BuchlerMW Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 2004 91 586 594 10.1002/bjs.448415122610 Search in Google Scholar

[12] Kuhlmann K, de Castro S, van Heek T, Busch O, van Gulik T, Obertop H, et al. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer. Surgery. 2006;139: 188–96. KuhlmannK de CastroS van HeekT BuschO van GulikT ObertopH Microscopically incomplete resection offers acceptable palliation in pancreatic cancer Surgery 2006 139 188 96 10.1016/j.surg.2005.06.03416455327 Search in Google Scholar

[13] Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, et al. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer. 2008;8:5. WestgaardA TafjordS FarstadIN CvancarovaM EideTJ MathisenO Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor BMC Cancer 2008 8 5 10.1186/1471-2407-8-5224958618194510 Search in Google Scholar

[14] Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. Br J Surg. 2006;93:1232–1237. VerbekeCS LeitchD MenonKV McMahonMJ GuillouPJ AnthoneyA Redefining the R1 resection in pancreatic cancer Br J Surg 2006 93 1232 1237 10.1002/bjs.539716804874 Search in Google Scholar

[15] Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008;15:1651–1660. EspositoI KleeffJ BergmannF ReiserC HerpelE FriessH Most pancreatic cancer resections are R1 resections Ann Surg Oncol 2008 15 1651 1660 10.1245/s10434-008-9839-818351300 Search in Google Scholar

[16] Campbell F, Smith RA, Whelan P, Sutton R, Raraty M, Neoptolemos JP, et al. Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin. Histopathology. 2009;55: 277–83. CampbellF SmithRA WhelanP SuttonR RaratyM NeoptolemosJP Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin Histopathology 2009 55 277 83 10.1111/j.1365-2559.2009.03376.x19723142 Search in Google Scholar

[17] Jamieson NB, Chan NI, Foulis AK, Dickson EJ, McKay CJ, Carter CR. The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2013;17:511–521. JamiesonNB ChanNI FoulisAK DicksonEJ McKayCJ CarterCR The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma J Gastrointest Surg 2013 17 511 521 10.1007/s11605-012-2131-z23297028 Search in Google Scholar

[18] Sobin LH, Gospodarowicz MK, Wittekind C. International Union Against Cancer. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009. SobinLH GospodarowiczMK WittekindC International Union Against Cancer. TNM classification of malignant tumours 7th ed. Oxford Wiley-Blackwell 2009 10.1002/9780471420194.tnmc26.pub2 Search in Google Scholar

[19] College of American Pathologists. Protocol for the examination of specimens from patients with carcinoma of the exocrine pancreas [Internet]. Northfield, IL: College of American Pathologists [cited 2015 Jun 1]. Available from: http://www.cap.org/web/home/resources/cancer-reporting-tools/cancer-protocol-templates. College of American Pathologists Protocol for the examination of specimens from patients with carcinoma of the exocrine pancreas [Internet] Northfield, IL College of American Pathologists [cited 2015 Jun 1]. Available from: http://www.cap.org/web/home/resources/cancer-reporting-tools/cancer-protocol-templates. Search in Google Scholar

[20] Latona, J.A., Lamb, K.M., Pucci, M.J. et al. J Gastrointest Surg (2016) 20: 300. https://doi.org/10.1007/s11605-015-3001-2 LatonaJ.A. LambK.M. PucciM.J J Gastrointest Surg 2016 20 300 https://doi.org/10.1007/s11605-015-3001-2 10.1007/s11605-015-3001-226525205 Search in Google Scholar

[21] Dhar P, Kalghatgi S, Saraf V. Pancreatic Cancer in Chronic Pancreatitis. Indian Journal of Surgical Oncology. 2015;6(1):57–62. doi:10.1007/s13193-014-0373-9. DharP KalghatgiS SarafV Pancreatic Cancer in Chronic Pancreatitis Indian Journal of Surgical Oncology 2015 6 1 57 62 10.1007/s13193-014-0373-9 441287025937765 Open DOISearch in Google Scholar

[22] Appleby Operation for Locally Advanced Tumour of the Pancreatic Body and Tail, Zentralbl Chir 2015; 140(2): 151–154 DOI: 10.1055/s-0035-1545837 Appleby Operation for Locally Advanced Tumour of the Pancreatic Body and Tail Zentralbl Chir 2015 140 2 151 154 10.1055/s-0035-1545837 25874466 Open DOISearch in Google Scholar